India, May 19 -- Reducing amyloid buildup in the brain may not improve cognition as strongly as some Alzheimer's drug ...

A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the ...

Please provide your email address to receive an email when new articles are posted on . Cell transformation begins with slow degeneration and progresses rapidly. The data confirmed results from ...

Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...

Alzheimer's patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows. The analysis found Alzheimer's disease continued to progress ...

A newly published study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits ...

Omics analysis is the process of analyzing large data sets to extract meaningful information about biological molecules—genes, DNA, RNA, proteins, metabolites or more—with the goal of illuminating ...

New research reveals a statistical technique used in Alzheimer's drug trials inflates clinical efficacy claims by 29x.

A common blood test marker may reveal Alzheimer’s risk years in advance. Elevated immune cells could signal danger early and may even contribute to the disease. Credit: Shutterstock A routine blood ...

GSK and Alector have stopped a phase 2 trial of their Alzheimer’s disease drug candidate after an interim analysis found the study was unlikely to hit its primary endpoint. The study randomized 367 ...

New AI-powered app analyses speech patterns to detect Alzheimer’s disease in its earliest stages, improving early diagnosis ...